For people suffering from depression, the electrical activity in certain areas of the brain is shown to be reduced.
The treatment is typically prescribed for patients who portray treatment-resistant depression (TRD). According to an article published in Biological Psychiatry by Maurizio Fava from the Harvard Medical School, up to 60% of patients show inadequate responses to their first antidepressant medication therapy.
Our treatment facility uses Magstim’s “Horizon Performance” TMS Therapy Machine. This cost-effective solution for depression offers fast patient throughput with relatively high remission, and low relapse rates.